Page last updated: 2024-09-04

resiquimod and Mycobacterium Infections

resiquimod has been researched along with Mycobacterium Infections in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (100.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Di Marco, S; Guilbault, C; Lachance, C; Matlashewski, G; Moisan, J; Radzioch, D; Skamene, E; Wojciechowski, W	1

Other Studies

1 other study(ies) available for resiquimod and Mycobacterium Infections

Article	Year
Clearance of infection with Mycobacterium bovis BCG in mice is enhanced by treatment with S28463 (R-848), and its efficiency depends on expression of wild-type Nramp1 (resistance allele). Antimicrobial agents and chemotherapy, 2001, Volume: 45, Issue:11 Topics: Alleles; Animals; Cation Transport Proteins; Cell Line; Colony Count, Microbial; Drug Resistance, Microbial; Gene Expression Regulation, Bacterial; Imidazoles; Macrophages; Mice; Mice, Knockout; Mycobacterium bovis; Mycobacterium Infections; Nitric Oxide; Spleen	2001

Article

Year

Clearance of infection with Mycobacterium bovis BCG in mice is enhanced by treatment with S28463 (R-848), and its efficiency depends on expression of wild-type Nramp1 (resistance allele).

Antimicrobial agents and chemotherapy, 2001, Volume: 45, Issue:11

Topics: Alleles; Animals; Cation Transport Proteins; Cell Line; Colony Count, Microbial; Drug Resistance, Microbial; Gene Expression Regulation, Bacterial; Imidazoles; Macrophages; Mice; Mice, Knockout; Mycobacterium bovis; Mycobacterium Infections; Nitric Oxide; Spleen

2001